Laurus Investment Counsel’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-75,234
| Closed | -$6.99M | – | 42 |
|
|
2021
Q1 | $6.99M | Sell |
75,234
-45,270
| -38% | -$4.21M | 2.69% | 17 |
|
|
2020
Q4 | $10.8M | Buy |
120,504
+510
| +0.4% | +$45.7K | 4.2% | 13 |
|
|
2020
Q3 | $12.4M | Sell |
119,994
-42,375
| -26% | -$4.38M | 6.09% | 6 |
|
|
2020
Q2 | $12.8M | Buy |
162,369
+88,200
| +119% | +$6.97M | 6.88% | 4 |
|
|
2020
Q1 | $4.29M | Buy |
74,169
+47,790
| +181% | +$2.76M | 3.1% | 15 |
|
|
2019
Q4 | $1.42M | Hold |
26,379
| – | – | 0.8% | 16 |
|
|
2019
Q3 | $1.38M | Buy |
+26,379
| New | +$1.38M | 0.94% | 17 |
|